Penumbra Inc
NYSE:PEN 4:00:00 PM EDT
| Market Cap (Intraday) | 7.85B |
| Current PE | 86.27 |
| Forward PE | 71.89 |
| 2yr Forward PE | 52.79 |
| 10-Day MA | $211.27 |
| 50-Day MA | $235.56 |
| 200-Day MA | $245.22 |
Penumbra Inc Stock, NYSE:PEN
One Penumbra Place, Alameda, California 94502
United States of America
Phone: +1.510.748.3200
Number of Employees: 4200
Description
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.